Steven K. Baker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Steven K. Baker has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Davyd R. Hooper
Neuromuscular and Electrodiagnostic Clinic Riverview Health Centre, University of Manitoba Winnipeg, Manitoba, Canada
3 shared publicationsMark A. Tarnopolsky
Department of Pediatrics,McMaster Children's Hospital,Hamilton,Ontario L8N 3Z5,Canada
3 shared publications- Steven Vernino
Department of Neurology, University of Texas Southwestern Medical Center, Dallas, USA
2 shared publications - Stuart Martin Phillips
Department of Kinesiology McMaster University Hamilton Ontario Canada
2 shared publications A. Alsolaihim
McMaster University
1 shared publication- Adrian R. Opala
Ken and Ruth Davee Department of Neurology, Division of Neuromuscular Disease, Northwestern University, Chicago, IL, USA
1 shared publication
Latest Publications
- Open Access
- 6 November 2024
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (5)
Medical Lysenkoism
Medicine is a compound field composed of science and art. The (necessary) degree to which the latter is involved opens medicine, in particular, to the introduction of ideas which do not, by their very nature, submit to confirmation or confutation as do the various methods of traditional science. This paper explores several ways in which a Lysenkoistic ideology can be interjected into medicine changing the manner in which it interacts with both patients and society. Simply, when ideology supersedes evidence the edifice of Western Medicine comes under direct threat. The exploration of this emerging ideological transition in medicine, and science more broadly, is of critical importance to determine the most salutary path forward.
- 6 November 2024
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 31 (5)
Open AccessMedical Lysenkoism
Medicine is a compound field composed of science and art. The (necessary) degree to which the latter is involved opens medicine, in particular, to the introduction of ideas which do not, by their very nature, submit to confirmation or confutation as do the various methods of traditional science. This paper explores several ways in which a Lysenkoistic ideology can be interjected into medicine changing the manner in which it interacts with both patients and society. Simply, when ideology supersedes evidence the edifice of Western Medicine comes under direct threat. The exploration of this emerging ideological transition in medicine, and science more broadly, is of critical importance to determine the most salutary path forward.
- 4 June 2023
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 29 (6) , 880-882
Activism contravenes consent
- 4 June 2023
- Published by Wiley in Journal of Evaluation in Clinical Practice
- Vol. 29 (6) , 880-882
Activism contravenes consent
- Open Access
- 15 October 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (1) , 135-137
Response from Authors to the Letter to the Editor
- 15 October 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 48 (1) , 135-137
Open AccessResponse from Authors to the Letter to the Editor
- Open Access
- 20 July 2020
- Published by Herald Scholarly Open Access
- Vol. 6 (2) , 1-8
Effectiveness Of An 8 Week Home Balance Training Program In CMT1A: A Pre And Post Intervention Study
Our investigation supports the role of at-home, balance training in improving gait and balance among CMT1A patients. The results and methodological considerations from our study may inform future studies in this area. Larger, comparative studies should be performed to elucidate the precise short-term and long-term effects of regular, at-home balance training in CMT disease.
- 20 July 2020
- Published by Herald Scholarly Open Access
- Vol. 6 (2) , 1-8
Open AccessEffectiveness Of An 8 Week Home Balance Training Program In CMT1A: A Pre And Post Intervention Study
Our investigation supports the role of at-home, balance training in improving gait and balance among CMT1A patients. The results and methodological considerations from our study may inform future studies in this area. Larger, comparative studies should be performed to elucidate the precise short-term and long-term effects of regular, at-home balance training in CMT disease.
- 1 July 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 47 (4) , 531-537
Chronic Inflammatory Demyelinating Polyneuropathy: Time to Maximal Recovery in Patients Receiving Intravenous Immunoglobulin Therapy
Background: The response of chronic inflammatory demyelinating polyneuropathy (CIDP) to intravenous immunoglobulins (IVIgs) treatment is well established. However, it remains unclear whether patients not responding to two IVIg treatments or those whose condition stabilizes (ICE trial) may benefit from additional doses. We aim to identify the time period required to reach maximal strength gains from IVIg treatment. Methods: Retrospective chart review of 14 patients with CIDP was performed. Change in handgrip (HG), Knee extension (KE), elbow flexion, and dorsiflexion was analyzed with a dynamometer during IVIg therapy. Strength improvements in Nm or kg, cumulative grams (g) of IVIg, and time in days required for maximal strength recovery were determined per function (+/- standard error of the mean). Ancillary therapy was recorded for all patients. Results: Improvements in strength of each function were significant (p < 0.05). Earliest improvement was in HG (137.07 +/- 21.23) and latest in KE (238.15 +/- 38.9). Majority of patients improved by 200 days of therapy. HG required the lowest cumulative grams of IgG (561.71 +/- 97.21) and KE the most (798 +/- 120.7). Conclusion: Our study has demonstrated the effectiveness of multiple treatments with IVIg to reach significant improvement in strength. Different muscle groups manifested different time dependency, reflecting the requirement of variable amounts of IVIg. Improvement was identified on an ongoing basis, with therapy lasting between 20.2 and 37.3 weeks, requiring between 562 and 798 g of IVIg.
- 1 July 2020
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- Vol. 47 (4) , 531-537
Chronic Inflammatory Demyelinating Polyneuropathy: Time to Maximal Recovery in Patients Receiving Intravenous Immunoglobulin Therapy
Background: The response of chronic inflammatory demyelinating polyneuropathy (CIDP) to intravenous immunoglobulins (IVIgs) treatment is well established. However, it remains unclear whether patients not responding to two IVIg treatments or those whose condition stabilizes (ICE trial) may benefit from additional doses. We aim to identify the time period required to reach maximal strength gains from IVIg treatment. Methods: Retrospective chart review of 14 patients with CIDP was performed. Change in handgrip (HG), Knee extension (KE), elbow flexion, and dorsiflexion was analyzed with a dynamometer during IVIg therapy. Strength improvements in Nm or kg, cumulative grams (g) of IVIg, and time in days required for maximal strength recovery were determined per function (+/- standard error of the mean). Ancillary therapy was recorded for all patients. Results: Improvements in strength of each function were significant (p < 0.05). Earliest improvement was in HG (137.07 +/- 21.23) and latest in KE (238.15 +/- 38.9). Majority of patients improved by 200 days of therapy. HG required the lowest cumulative grams of IgG (561.71 +/- 97.21) and KE the most (798 +/- 120.7). Conclusion: Our study has demonstrated the effectiveness of multiple treatments with IVIg to reach significant improvement in strength. Different muscle groups manifested different time dependency, reflecting the requirement of variable amounts of IVIg. Improvement was identified on an ongoing basis, with therapy lasting between 20.2 and 37.3 weeks, requiring between 562 and 798 g of IVIg.
- Open Access
Potato Protein Isolate Stimulates Muscle Protein Synthesis at Rest and with Resistance Exercise in Young Women
Skeletal muscle myofibrillar protein synthesis (MPS) increases in response to protein feeding and to resistance exercise (RE), where each stimuli acts synergistically when combined. The efficacy of plant proteins such as potato protein (PP) isolate to stimulate MPS is unknown. We aimed to determine the effects of PP ingestion on daily MPS with and without RE in healthy women. In a single blind, parallel-group design, 24 young women (21 ± 3 years, n = 12/group) consumed a weight-maintaining baseline diet containing 0.8 g/kg/d of protein before being randomized to consume either 25 g of PP twice daily (1.6 g/kg/d total protein) or a control diet (CON) (0.8 g/kg/d total protein) for 2 wks. Unilateral RE (~30% of maximal strength to failure) was performed thrice weekly with the opposite limb serving as a non-exercised control (Rest). MPS was measured by deuterated water ingestion at baseline, following supplementation (Rest), and following supplementation + RE (Exercise). Ingestion of PP stimulated MPS by 0.14 ± 0.09 %/d at Rest, and by 0.32 ± 0.14 %/d in the Exercise limb. MPS was significantly elevated by 0.20 ± 0.11 %/d in the Exercise limb in CON (p = 0.008). Consuming PP to increase protein intake to levels twice the recommended dietary allowance for protein augmented rates of MPS. Performance of RE stimulated MPS regardless of protein intake. PP is a high-quality, plant-based protein supplement that augments MPS at rest and following RE in healthy young women.
Open AccessPotato Protein Isolate Stimulates Muscle Protein Synthesis at Rest and with Resistance Exercise in Young Women
Skeletal muscle myofibrillar protein synthesis (MPS) increases in response to protein feeding and to resistance exercise (RE), where each stimuli acts synergistically when combined. The efficacy of plant proteins such as potato protein (PP) isolate to stimulate MPS is unknown. We aimed to determine the effects of PP ingestion on daily MPS with and without RE in healthy women. In a single blind, parallel-group design, 24 young women (21 ± 3 years, n = 12/group) consumed a weight-maintaining baseline diet containing 0.8 g/kg/d of protein before being randomized to consume either 25 g of PP twice daily (1.6 g/kg/d total protein) or a control diet (CON) (0.8 g/kg/d total protein) for 2 wks. Unilateral RE (~30% of maximal strength to failure) was performed thrice weekly with the opposite limb serving as a non-exercised control (Rest). MPS was measured by deuterated water ingestion at baseline, following supplementation (Rest), and following supplementation + RE (Exercise). Ingestion of PP stimulated MPS by 0.14 ± 0.09 %/d at Rest, and by 0.32 ± 0.14 %/d in the Exercise limb. MPS was significantly elevated by 0.20 ± 0.11 %/d in the Exercise limb in CON (p = 0.008). Consuming PP to increase protein intake to levels twice the recommended dietary allowance for protein augmented rates of MPS. Performance of RE stimulated MPS regardless of protein intake. PP is a high-quality, plant-based protein supplement that augments MPS at rest and following RE in healthy young women.
- 1 March 2020
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (3) , 232-235
Phenotypic convergence in Charcot-Marie-Tooth 2Y with novel VCP mutation
- 1 March 2020
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (3) , 232-235
Phenotypic convergence in Charcot-Marie-Tooth 2Y with novel VCP mutation
- Open Access
- 14 February 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (1) , 73-77
Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is characterized by a slowly progressive sensory and motor involvement lasting at least 2 months. We present a CIDP patient on subcutaneous Ig (SCIg). Upon fine-tuning his dose from 24 to 28 g/week, this showed a dramatic improvement in both hand grip (13–25%) and dorsiflexion (73–278%). Follow-up nerve conduction studies also demonstrated significant improvements in latencies, motor amplitudes, and conduction velocities. Ongoing surveillance of CIDP patients receiving SCIg therapy is therefore necessary to ensure therapeutic optimization.
- 14 February 2020
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 12 (1) , 73-77
Open AccessDose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is characterized by a slowly progressive sensory and motor involvement lasting at least 2 months. We present a CIDP patient on subcutaneous Ig (SCIg). Upon fine-tuning his dose from 24 to 28 g/week, this showed a dramatic improvement in both hand grip (13–25%) and dorsiflexion (73–278%). Follow-up nerve conduction studies also demonstrated significant improvements in latencies, motor amplitudes, and conduction velocities. Ongoing surveillance of CIDP patients receiving SCIg therapy is therefore necessary to ensure therapeutic optimization.